Cargando…

Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection

OBJECTIVE: Gastric endoscopic submucosal dissection (ESD) is currently a standard procedure, and proton pump inhibitors (PPIs) are most commonly used to treat post-ESD ulcers. Vonoprazan, a potassium-competitive acid blocker (P-CAB), reportedly inhibits gastric acid secretions more effectively than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichida, Takashi, Ueyama, Syunsuke, Eto, Tetsuya, Kusano, Fumihiko, Sakai, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378166/ https://www.ncbi.nlm.nih.gov/pubmed/30210115 http://dx.doi.org/10.2169/internalmedicine.1146-18

Ejemplares similares

A Case-Control Study of Esomeprazole Plus Rebamipide vs. Omeprazole Plus Rebamipide on Post-ESD Gastric Ulcers
por: Bunno, Maki, et al.
Publicado: (2013)

Effects of esomeprazole on the healing process of post-endoscopic submucosal dissection gastric ulcers: a single arm, prospective trial
por: Ichida, Takashi, et al.
Publicado: (2016)

A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers
por: Yan, Bin, et al.
Publicado: (2019)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy
por: Nakamura, Kazuhiko, et al.
Publicado: (2016)

The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study
por: Hong, Su Jin, et al.
Publicado: (2016)

Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial
por: Ishii, Yasuaki, et al.
Publicado: (2018)

Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm
por: Araki, Hiroshi, et al.
Publicado: (2012)

Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014)

Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
por: Liu, Junyuan, et al.
Publicado: (2020)

Notice of Retraction: Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials
Publicado: (2014)

Rebamipide and mosapride enhance pilocarpine-induced salivation
por: Urita, Yoshihisa, et al.
Publicado: (2009)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

Topical rebamipide improves lid wiper epitheliopathy
por: Itakura, Hirotaka, et al.
Publicado: (2013)

Rebamipide: A Novel Agent in the Treatment of Recurrent Aphthous Ulcer and Behcet's Syndrome
por: Kudur, Mohan H, et al.
Publicado: (2013)

Topical rebamipide improves the ocular surface in mild lagophthalmos
por: Itakura, Mariko, et al.
Publicado: (2013)

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation
por: Jhun, JooYeon, et al.
Publicado: (2017)

Resolution of persistent corneal erosion after administration of topical rebamipide
por: Kashima, Tomoyuki, et al.
Publicado: (2012)

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012)

Rebamipide Delivered by Brushite Cement Enhances Osteoblast and Macrophage Proliferation
por: Pujari-Palmer, Michael, et al.
Publicado: (2015)

Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye
por: Igarashi, Tsutomu, et al.
Publicado: (2018)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Small Bowel Tissue Concentration of Rebamipide: Study of Two Dosages in Healthy Subjects
por: Akamatsu, Taiji, et al.
Publicado: (2010)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study
por: Ko, Jihwan, et al.
Publicado: (2019)

Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles
por: Nagai, Noriaki, et al.
Publicado: (2020)

Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease
por: Jang, Eunkyeong, et al.
Publicado: (2022)

Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease
por: Gweon, Tae-Geun, et al.
Publicado: (2018)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
por: Fujimoto, Masahiro, et al.
Publicado: (2014)

Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy
por: Kato, Kumiko, et al.
Publicado: (2016)

Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis
por: Izawa, Takashi, et al.
Publicado: (2018)

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus
por: Park, Sejeong, et al.
Publicado: (2016)

Proteomic Analysis of Dacryoliths from Patients with or without Topical Rebamipide Treatment
por: Mano, Fukutaro, et al.
Publicado: (2018)

The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes
por: Jhun, JooYeon, et al.
Publicado: (2022)

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
por: Kashima, Tomoyuki, et al.
Publicado: (2014)

The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients
por: Tokuda, Naoto, et al.
Publicado: (2015)

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
por: Ueda, Kaori, et al.
Publicado: (2015)

Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
por: Sasaki, Hidenori, et al.
Publicado: (2014)

Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
por: Kawaguchi, Ichiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ogprvm13p504qvbuvjqd7oeo4o